WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) reported on
Friday that net income for the fourth quarter declined 3 percent to $1.16
billion or $10.19 per share from $1.20 billion or $10.50 per share in the
prior-year quarter.

Excluding items, adjusted earnings for the quarter $1.37 billion or $11.86 per
share, compared to $1.45 billion or $12.56 per share in the year-ago quarter.

On average, 21 analysts polled by Thomson Reuters expected the company to report
earnings of $10.87 per share for the quarter. Analysts' estimates typically
exclude special items.

Total revenue for the quarter edged up 1 percent to $3.43 billion from $3.41
billion in the same quarter last year. Excluding Ronapreve, revenue grew 14
percent. Analysts were looking for revenues of $3.29 billion for the quarter.

For more earnings news, earnings calendar, and earnings for stocks, visit
rttnews.com



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX